Form 8-K · Current report
Boeing 8-K, filed Oct 27, 2026
- Filed
- CIK
- 0000012927
- Accession no.
- 0001628280-26-067411
Summary
Boeing reported third-quarter 2026 revenue of $24.2 billion, a GAAP net loss of $116 million, operating cash flow of $1.5 billion, and free cash flow of $0.5 billion. The company said the 737-7 received amended type certification from the FAA, the 737-10 received certification in October, and it was selected by the U.S. Navy to design, build and deliver the F/A-XX next-generation fighter aircraft.
Key points
- Boeing reported third-quarter 2026 revenue of $24.2 billion, a GAAP net loss of $116 million, operating cash flow of $1.5 billion, and free cash flow of $0.5 billion.
- The 737-7 received amended type certification from the FAA, and the 737-10 received certification in October.
- Boeing was selected by the U.S. Navy to design, build and deliver the F/A-XX next-generation fighter aircraft.
- Total company backlog grew to a record $745 billion, including over 6,300 commercial airplanes valued at $612 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 27, 2026, The Boeing Company issued a press release reporting its financial results for the third quarter of 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by The Boeing Company dated October 27, 2026, reporting Boeing's financial results for the third quarter of 2026, furnished herewith. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.